nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA6—submandibular gland—head and neck cancer	0.0469	0.12	CbGeAlD
Zonisamide—CA13—tongue—head and neck cancer	0.0175	0.0447	CbGeAlD
Zonisamide—CA6—saliva—head and neck cancer	0.0169	0.043	CbGeAlD
Zonisamide—CA6—ear—head and neck cancer	0.0154	0.0393	CbGeAlD
Zonisamide—CA3—ear—head and neck cancer	0.0146	0.0373	CbGeAlD
Zonisamide—CA13—mouth—head and neck cancer	0.0118	0.0301	CbGeAlD
Zonisamide—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.0103	0.0258	CcSEcCtD
Zonisamide—CA6—exocrine gland—head and neck cancer	0.00853	0.0218	CbGeAlD
Zonisamide—CA6—hair follicle—head and neck cancer	0.00813	0.0207	CbGeAlD
Zonisamide—SCN4B—parotid gland—head and neck cancer	0.00801	0.0204	CbGeAlD
Zonisamide—Developmental delay—Fluorouracil—head and neck cancer	0.00729	0.0182	CcSEcCtD
Zonisamide—Congenital anomaly—Fluorouracil—head and neck cancer	0.00729	0.0182	CcSEcCtD
Zonisamide—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00696	0.0174	CcSEcCtD
Zonisamide—CA11—saliva-secreting gland—head and neck cancer	0.0066	0.0168	CbGeAlD
Zonisamide—SCN2B—thyroid gland—head and neck cancer	0.0066	0.0168	CbGeAlD
Zonisamide—CA6—mouth—head and neck cancer	0.00638	0.0163	CbGeAlD
Zonisamide—Peptic ulcer—Vinblastine—head and neck cancer	0.00632	0.0158	CcSEcCtD
Zonisamide—CA3—mouth—head and neck cancer	0.00604	0.0154	CbGeAlD
Zonisamide—SCN1B—thyroid gland—head and neck cancer	0.00597	0.0152	CbGeAlD
Zonisamide—SCN4B—trachea—head and neck cancer	0.00592	0.0151	CbGeAlD
Zonisamide—Nystagmus—Vinblastine—head and neck cancer	0.00591	0.0148	CcSEcCtD
Zonisamide—SCN2B—head—head and neck cancer	0.00585	0.0149	CbGeAlD
Zonisamide—Neuritis—Vinblastine—head and neck cancer	0.00566	0.0141	CcSEcCtD
Zonisamide—CA8—thyroid gland—head and neck cancer	0.00561	0.0143	CbGeAlD
Zonisamide—SCN3B—thyroid gland—head and neck cancer	0.00551	0.014	CbGeAlD
Zonisamide—Lupus erythematosus—Docetaxel—head and neck cancer	0.00537	0.0134	CcSEcCtD
Zonisamide—SCN1B—head—head and neck cancer	0.00529	0.0135	CbGeAlD
Zonisamide—CA11—trachea—head and neck cancer	0.00509	0.013	CbGeAlD
Zonisamide—CA10—head—head and neck cancer	0.00507	0.0129	CbGeAlD
Zonisamide—CA8—head—head and neck cancer	0.00498	0.0127	CbGeAlD
Zonisamide—SCN3B—head—head and neck cancer	0.00488	0.0125	CbGeAlD
Zonisamide—CA13—thyroid gland—head and neck cancer	0.0048	0.0122	CbGeAlD
Zonisamide—SCN4B—thyroid gland—head and neck cancer	0.00468	0.0119	CbGeAlD
Zonisamide—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00468	0.0117	CcSEcCtD
Zonisamide—CA6—parotid gland—head and neck cancer	0.00444	0.0113	CbGeAlD
Zonisamide—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00438	0.0109	CcSEcCtD
Zonisamide—Encephalopathy—Fluorouracil—head and neck cancer	0.00432	0.0108	CcSEcCtD
Zonisamide—CA13—head—head and neck cancer	0.00426	0.0109	CbGeAlD
Zonisamide—CA6—saliva-secreting gland—head and neck cancer	0.00426	0.0109	CbGeAlD
Zonisamide—CA3—parotid gland—head and neck cancer	0.00421	0.0107	CbGeAlD
Zonisamide—SCN4B—head—head and neck cancer	0.00415	0.0106	CbGeAlD
Zonisamide—CA11—thyroid gland—head and neck cancer	0.00403	0.0103	CbGeAlD
Zonisamide—Photophobia—Vinblastine—head and neck cancer	0.00397	0.0099	CcSEcCtD
Zonisamide—Nystagmus—Fluorouracil—head and neck cancer	0.00388	0.00969	CcSEcCtD
Zonisamide—SCN1B—lymph node—head and neck cancer	0.00371	0.00945	CbGeAlD
Zonisamide—CA3—connective tissue—head and neck cancer	0.0037	0.00944	CbGeAlD
Zonisamide—Blood urea increased—Hydroxyurea—head and neck cancer	0.00364	0.00908	CcSEcCtD
Zonisamide—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00361	0.00902	CcSEcCtD
Zonisamide—CA11—head—head and neck cancer	0.00358	0.00912	CbGeAlD
Zonisamide—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.0035	0.00874	CcSEcCtD
Zonisamide—CA8—lymph node—head and neck cancer	0.00348	0.00889	CbGeAlD
Zonisamide—Deafness—Vinblastine—head and neck cancer	0.00343	0.00856	CcSEcCtD
Zonisamide—SCN3B—lymph node—head and neck cancer	0.00342	0.00872	CbGeAlD
Zonisamide—CA7—trachea—head and neck cancer	0.00339	0.00864	CbGeAlD
Zonisamide—Speech disorder—Fluorouracil—head and neck cancer	0.00322	0.00805	CcSEcCtD
Zonisamide—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00313	0.00781	CcSEcCtD
Zonisamide—Parosmia—Docetaxel—head and neck cancer	0.00309	0.0077	CcSEcCtD
Zonisamide—CA13—lymph node—head and neck cancer	0.00298	0.0076	CbGeAlD
Zonisamide—Leukocytosis—Fluorouracil—head and neck cancer	0.00295	0.00736	CcSEcCtD
Zonisamide—CA2—exocrine gland—head and neck cancer	0.00294	0.00749	CbGeAlD
Zonisamide—Dysarthria—Fluorouracil—head and neck cancer	0.00293	0.00732	CcSEcCtD
Zonisamide—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00293	0.0073	CcSEcCtD
Zonisamide—SCN11A—head—head and neck cancer	0.00291	0.00743	CbGeAlD
Zonisamide—SCN4B—lymph node—head and neck cancer	0.00291	0.00742	CbGeAlD
Zonisamide—CACNA1I—lymph node—head and neck cancer	0.00284	0.00724	CbGeAlD
Zonisamide—CA2—hair follicle—head and neck cancer	0.0028	0.00714	CbGeAlD
Zonisamide—CACNA1G—head—head and neck cancer	0.00278	0.00709	CbGeAlD
Zonisamide—Face oedema—Hydroxyurea—head and neck cancer	0.0027	0.00674	CcSEcCtD
Zonisamide—Neuritis—Docetaxel—head and neck cancer	0.00268	0.00669	CcSEcCtD
Zonisamide—Scotoma—Docetaxel—head and neck cancer	0.00264	0.00658	CcSEcCtD
Zonisamide—CA12—connective tissue—head and neck cancer	0.00262	0.00669	CbGeAlD
Zonisamide—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00262	0.00654	CcSEcCtD
Zonisamide—Photophobia—Fluorouracil—head and neck cancer	0.0026	0.0065	CcSEcCtD
Zonisamide—Coma—Fluorouracil—head and neck cancer	0.00253	0.00632	CcSEcCtD
Zonisamide—Oesophagitis—Fluorouracil—head and neck cancer	0.00253	0.00632	CcSEcCtD
Zonisamide—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00252	0.00629	CcSEcCtD
Zonisamide—Pancytopenia—Vinblastine—head and neck cancer	0.00252	0.00628	CcSEcCtD
Zonisamide—CA11—lymph node—head and neck cancer	0.0025	0.00638	CbGeAlD
Zonisamide—CA3—thyroid gland—head and neck cancer	0.00246	0.00627	CbGeAlD
Zonisamide—Euphoric mood—Fluorouracil—head and neck cancer	0.00238	0.00595	CcSEcCtD
Zonisamide—Pancreatitis—Hydroxyurea—head and neck cancer	0.00237	0.00591	CcSEcCtD
Zonisamide—Depression—Vinblastine—head and neck cancer	0.00236	0.00588	CcSEcCtD
Zonisamide—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00232	0.0058	CcSEcCtD
Zonisamide—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00232	0.00578	CcSEcCtD
Zonisamide—CA6—head—head and neck cancer	0.0023	0.00588	CbGeAlD
Zonisamide—Pancytopenia—Hydroxyurea—head and neck cancer	0.00229	0.00573	CcSEcCtD
Zonisamide—Amenorrhoea—Docetaxel—head and neck cancer	0.00228	0.00569	CcSEcCtD
Zonisamide—CA4—neck—head and neck cancer	0.00227	0.00578	CbGeAlD
Zonisamide—Dysuria—Hydroxyurea—head and neck cancer	0.00226	0.00564	CcSEcCtD
Zonisamide—Agranulocytosis—Vinblastine—head and neck cancer	0.0022	0.0055	CcSEcCtD
Zonisamide—CA12—trachea—head and neck cancer	0.0022	0.00561	CbGeAlD
Zonisamide—Weight increased—Hydroxyurea—head and neck cancer	0.0022	0.00549	CcSEcCtD
Zonisamide—CA2—mouth—head and neck cancer	0.0022	0.0056	CbGeAlD
Zonisamide—CA3—head—head and neck cancer	0.00218	0.00556	CbGeAlD
Zonisamide—Amnesia—Fluorouracil—head and neck cancer	0.00214	0.00535	CcSEcCtD
Zonisamide—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00211	0.00527	CcSEcCtD
Zonisamide—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00211	0.00526	CcSEcCtD
Zonisamide—Pharyngitis—Vinblastine—head and neck cancer	0.00211	0.00526	CcSEcCtD
Zonisamide—Stomatitis—Hydroxyurea—head and neck cancer	0.0021	0.00524	CcSEcCtD
Zonisamide—Cardiac failure—Fluorouracil—head and neck cancer	0.00206	0.00515	CcSEcCtD
Zonisamide—CACNA1H—thyroid gland—head and neck cancer	0.00205	0.00523	CbGeAlD
Zonisamide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00204	0.00509	CcSEcCtD
Zonisamide—Osteoarthritis—Fluorouracil—head and neck cancer	0.00201	0.00502	CcSEcCtD
Zonisamide—MAOA—neck—head and neck cancer	0.00201	0.00512	CbGeAlD
Zonisamide—Hepatocellular injury—Docetaxel—head and neck cancer	0.002	0.005	CcSEcCtD
Zonisamide—Pulmonary embolism—Docetaxel—head and neck cancer	0.002	0.005	CcSEcCtD
Zonisamide—SCN4A—thyroid gland—head and neck cancer	0.00195	0.00498	CbGeAlD
Zonisamide—Influenza like illness—Docetaxel—head and neck cancer	0.00194	0.00485	CcSEcCtD
Zonisamide—Hallucination—Hydroxyurea—head and neck cancer	0.00192	0.0048	CcSEcCtD
Zonisamide—Colitis—Docetaxel—head and neck cancer	0.00192	0.0048	CcSEcCtD
Zonisamide—Irritability—Fluorouracil—head and neck cancer	0.00192	0.0048	CcSEcCtD
Zonisamide—MAOB—parotid gland—head and neck cancer	0.00192	0.00489	CbGeAlD
Zonisamide—Ataxia—Fluorouracil—head and neck cancer	0.00189	0.00472	CcSEcCtD
Zonisamide—Neuropathy—Docetaxel—head and neck cancer	0.00188	0.00469	CcSEcCtD
Zonisamide—CA2—neck—head and neck cancer	0.00188	0.00479	CbGeAlD
Zonisamide—Alopecia—Vinblastine—head and neck cancer	0.00187	0.00468	CcSEcCtD
Zonisamide—CA4—parotid gland—head and neck cancer	0.00184	0.00471	CbGeAlD
Zonisamide—Dry skin—Fluorouracil—head and neck cancer	0.00184	0.00461	CcSEcCtD
Zonisamide—AOX1—trachea—head and neck cancer	0.00184	0.00468	CbGeAlD
Zonisamide—MAOB—saliva-secreting gland—head and neck cancer	0.00183	0.00468	CbGeAlD
Zonisamide—Oesophagitis—Docetaxel—head and neck cancer	0.00183	0.00456	CcSEcCtD
Zonisamide—Muscular weakness—Fluorouracil—head and neck cancer	0.00178	0.00443	CcSEcCtD
Zonisamide—CA4—saliva-secreting gland—head and neck cancer	0.00177	0.00451	CbGeAlD
Zonisamide—Dysphagia—Fluorouracil—head and neck cancer	0.00174	0.00434	CcSEcCtD
Zonisamide—SCN4A—head—head and neck cancer	0.00173	0.00442	CbGeAlD
Zonisamide—Eosinophilia—Fluorouracil—head and neck cancer	0.00172	0.0043	CcSEcCtD
Zonisamide—Ill-defined disorder—Vinblastine—head and neck cancer	0.00171	0.00428	CcSEcCtD
Zonisamide—Alopecia—Hydroxyurea—head and neck cancer	0.00171	0.00427	CcSEcCtD
Zonisamide—Anaemia—Vinblastine—head and neck cancer	0.00171	0.00426	CcSEcCtD
Zonisamide—MAOB—connective tissue—head and neck cancer	0.00169	0.0043	CbGeAlD
Zonisamide—Thrombophlebitis—Docetaxel—head and neck cancer	0.00168	0.00419	CcSEcCtD
Zonisamide—SCN1A—head—head and neck cancer	0.00167	0.00426	CbGeAlD
Zonisamide—Malaise—Vinblastine—head and neck cancer	0.00167	0.00416	CcSEcCtD
Zonisamide—Vertigo—Vinblastine—head and neck cancer	0.00166	0.00414	CcSEcCtD
Zonisamide—Leukopenia—Vinblastine—head and neck cancer	0.00165	0.00413	CcSEcCtD
Zonisamide—Pancytopenia—Fluorouracil—head and neck cancer	0.00165	0.00412	CcSEcCtD
Zonisamide—MAOA—parotid gland—head and neck cancer	0.00163	0.00417	CbGeAlD
Zonisamide—Deafness—Docetaxel—head and neck cancer	0.00162	0.00405	CcSEcCtD
Zonisamide—Convulsion—Vinblastine—head and neck cancer	0.0016	0.00399	CcSEcCtD
Zonisamide—Hypertension—Vinblastine—head and neck cancer	0.00159	0.00398	CcSEcCtD
Zonisamide—MAOA—saliva-secreting gland—head and neck cancer	0.00157	0.00399	CbGeAlD
Zonisamide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00156	0.0039	CcSEcCtD
Zonisamide—CA5B—thyroid gland—head and neck cancer	0.00156	0.00398	CbGeAlD
Zonisamide—Pneumonia—Fluorouracil—head and neck cancer	0.00156	0.00389	CcSEcCtD
Zonisamide—Anaemia—Hydroxyurea—head and neck cancer	0.00156	0.00389	CcSEcCtD
Zonisamide—Discomfort—Vinblastine—head and neck cancer	0.00155	0.00388	CcSEcCtD
Zonisamide—CA12—head—head and neck cancer	0.00154	0.00394	CbGeAlD
Zonisamide—Atrial fibrillation—Docetaxel—head and neck cancer	0.00153	0.00383	CcSEcCtD
Zonisamide—SCN2A—head—head and neck cancer	0.00153	0.00391	CbGeAlD
Zonisamide—CA2—parotid gland—head and neck cancer	0.00153	0.0039	CbGeAlD
Zonisamide—CA3—lymph node—head and neck cancer	0.00153	0.0039	CbGeAlD
Zonisamide—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00152	0.0038	CcSEcCtD
Zonisamide—Dermatitis bullous—Docetaxel—head and neck cancer	0.00152	0.00379	CcSEcCtD
Zonisamide—CA1—lymphoid tissue—head and neck cancer	0.00152	0.00387	CbGeAlD
Zonisamide—Malaise—Hydroxyurea—head and neck cancer	0.00152	0.00379	CcSEcCtD
Zonisamide—SCN3A—thyroid gland—head and neck cancer	0.00152	0.00387	CbGeAlD
Zonisamide—Stomatitis—Fluorouracil—head and neck cancer	0.00151	0.00377	CcSEcCtD
Zonisamide—Conjunctivitis—Fluorouracil—head and neck cancer	0.00151	0.00376	CcSEcCtD
Zonisamide—Urinary tract infection—Fluorouracil—head and neck cancer	0.00151	0.00376	CcSEcCtD
Zonisamide—Leukopenia—Hydroxyurea—head and neck cancer	0.00151	0.00376	CcSEcCtD
Zonisamide—Cardiac failure—Docetaxel—head and neck cancer	0.00149	0.00372	CcSEcCtD
Zonisamide—Thrombocytopenia—Vinblastine—head and neck cancer	0.00148	0.00368	CcSEcCtD
Zonisamide—CA2—saliva-secreting gland—head and neck cancer	0.00147	0.00374	CbGeAlD
Zonisamide—Convulsion—Hydroxyurea—head and neck cancer	0.00146	0.00364	CcSEcCtD
Zonisamide—Hyponatraemia—Docetaxel—head and neck cancer	0.00146	0.00364	CcSEcCtD
Zonisamide—AOX1—thyroid gland—head and neck cancer	0.00145	0.00371	CbGeAlD
Zonisamide—Agranulocytosis—Fluorouracil—head and neck cancer	0.00145	0.00361	CcSEcCtD
Zonisamide—MAOA—connective tissue—head and neck cancer	0.00144	0.00367	CbGeAlD
Zonisamide—Anorexia—Vinblastine—head and neck cancer	0.00144	0.00359	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00142	0.00355	CcSEcCtD
Zonisamide—Discomfort—Hydroxyurea—head and neck cancer	0.00142	0.00354	CcSEcCtD
Zonisamide—Rhinitis—Fluorouracil—head and neck cancer	0.0014	0.00348	CcSEcCtD
Zonisamide—CA5B—head—head and neck cancer	0.00139	0.00353	CbGeAlD
Zonisamide—Pharyngitis—Fluorouracil—head and neck cancer	0.00138	0.00345	CcSEcCtD
Zonisamide—Oedema—Hydroxyurea—head and neck cancer	0.00137	0.00343	CcSEcCtD
Zonisamide—Ataxia—Docetaxel—head and neck cancer	0.00137	0.00341	CcSEcCtD
Zonisamide—Infection—Hydroxyurea—head and neck cancer	0.00137	0.00341	CcSEcCtD
Zonisamide—CA4—trachea—head and neck cancer	0.00136	0.00348	CbGeAlD
Zonisamide—SCN9A—lymph node—head and neck cancer	0.00136	0.00347	CbGeAlD
Zonisamide—Paraesthesia—Vinblastine—head and neck cancer	0.00135	0.00338	CcSEcCtD
Zonisamide—Dehydration—Docetaxel—head and neck cancer	0.00135	0.00337	CcSEcCtD
Zonisamide—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00135	0.00336	CcSEcCtD
Zonisamide—SCN3A—head—head and neck cancer	0.00135	0.00343	CbGeAlD
Zonisamide—CA2—connective tissue—head and neck cancer	0.00135	0.00343	CbGeAlD
Zonisamide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00135	0.00336	CcSEcCtD
Zonisamide—SCN5A—head—head and neck cancer	0.00134	0.00343	CbGeAlD
Zonisamide—Liver function test abnormal—Docetaxel—head and neck cancer	0.00134	0.00335	CcSEcCtD
Zonisamide—Skin disorder—Hydroxyurea—head and neck cancer	0.00133	0.00333	CcSEcCtD
Zonisamide—Dry skin—Docetaxel—head and neck cancer	0.00133	0.00332	CcSEcCtD
Zonisamide—Anorexia—Hydroxyurea—head and neck cancer	0.00131	0.00327	CcSEcCtD
Zonisamide—Decreased appetite—Vinblastine—head and neck cancer	0.00131	0.00327	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00131	0.00327	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00131	0.00327	CcSEcCtD
Zonisamide—Constipation—Vinblastine—head and neck cancer	0.00129	0.00322	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00128	0.0032	CcSEcCtD
Zonisamide—CA2—epithelium—head and neck cancer	0.00128	0.00326	CbGeAlD
Zonisamide—CACNA1H—lymph node—head and neck cancer	0.00127	0.00325	CbGeAlD
Zonisamide—Dysphagia—Docetaxel—head and neck cancer	0.00126	0.00313	CcSEcCtD
Zonisamide—Feeling abnormal—Vinblastine—head and neck cancer	0.00124	0.0031	CcSEcCtD
Zonisamide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00123	0.00308	CcSEcCtD
Zonisamide—Alopecia—Fluorouracil—head and neck cancer	0.00123	0.00307	CcSEcCtD
Zonisamide—Dyspnoea—Hydroxyurea—head and neck cancer	0.00123	0.00306	CcSEcCtD
Zonisamide—CA1—head—head and neck cancer	0.00122	0.00312	CbGeAlD
Zonisamide—Somnolence—Hydroxyurea—head and neck cancer	0.00122	0.00305	CcSEcCtD
Zonisamide—Dyspepsia—Hydroxyurea—head and neck cancer	0.00121	0.00302	CcSEcCtD
Zonisamide—MAOA—trachea—head and neck cancer	0.00121	0.00308	CbGeAlD
Zonisamide—Decreased appetite—Hydroxyurea—head and neck cancer	0.00119	0.00298	CcSEcCtD
Zonisamide—Pancytopenia—Docetaxel—head and neck cancer	0.00119	0.00298	CcSEcCtD
Zonisamide—Abdominal pain—Vinblastine—head and neck cancer	0.00119	0.00297	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00119	0.00296	CcSEcCtD
Zonisamide—Fatigue—Hydroxyurea—head and neck cancer	0.00118	0.00296	CcSEcCtD
Zonisamide—Constipation—Hydroxyurea—head and neck cancer	0.00118	0.00293	CcSEcCtD
Zonisamide—Weight increased—Docetaxel—head and neck cancer	0.00114	0.00285	CcSEcCtD
Zonisamide—Weight decreased—Docetaxel—head and neck cancer	0.00114	0.00284	CcSEcCtD
Zonisamide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00113	0.00283	CcSEcCtD
Zonisamide—CA2—trachea—head and neck cancer	0.00113	0.00288	CbGeAlD
Zonisamide—Pneumonia—Docetaxel—head and neck cancer	0.00113	0.00281	CcSEcCtD
Zonisamide—Anaemia—Fluorouracil—head and neck cancer	0.00112	0.0028	CcSEcCtD
Zonisamide—MAOB—thyroid gland—head and neck cancer	0.00112	0.00286	CbGeAlD
Zonisamide—Hypersensitivity—Vinblastine—head and neck cancer	0.00111	0.00277	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00111	0.00277	CcSEcCtD
Zonisamide—Renal failure—Docetaxel—head and neck cancer	0.0011	0.00275	CcSEcCtD
Zonisamide—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0011	0.00274	CcSEcCtD
Zonisamide—Stomatitis—Docetaxel—head and neck cancer	0.00109	0.00272	CcSEcCtD
Zonisamide—Conjunctivitis—Docetaxel—head and neck cancer	0.00109	0.00272	CcSEcCtD
Zonisamide—Body temperature increased—Hydroxyurea—head and neck cancer	0.00109	0.00271	CcSEcCtD
Zonisamide—Leukopenia—Fluorouracil—head and neck cancer	0.00108	0.00271	CcSEcCtD
Zonisamide—Asthenia—Vinblastine—head and neck cancer	0.00108	0.0027	CcSEcCtD
Zonisamide—CA4—thyroid gland—head and neck cancer	0.00108	0.00275	CbGeAlD
Zonisamide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00106	0.00264	CcSEcCtD
Zonisamide—Convulsion—Fluorouracil—head and neck cancer	0.00105	0.00262	CcSEcCtD
Zonisamide—Agranulocytosis—Docetaxel—head and neck cancer	0.00104	0.00261	CcSEcCtD
Zonisamide—Chest pain—Fluorouracil—head and neck cancer	0.00103	0.00258	CcSEcCtD
Zonisamide—Myalgia—Fluorouracil—head and neck cancer	0.00103	0.00258	CcSEcCtD
Zonisamide—Diarrhoea—Vinblastine—head and neck cancer	0.00103	0.00257	CcSEcCtD
Zonisamide—Discomfort—Fluorouracil—head and neck cancer	0.00102	0.00254	CcSEcCtD
Zonisamide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00101	0.00253	CcSEcCtD
Zonisamide—Rhinitis—Docetaxel—head and neck cancer	0.00101	0.00251	CcSEcCtD
Zonisamide—Confusional state—Fluorouracil—head and neck cancer	0.000997	0.00249	CcSEcCtD
Zonisamide—Pharyngitis—Docetaxel—head and neck cancer	0.000997	0.00249	CcSEcCtD
Zonisamide—Dizziness—Vinblastine—head and neck cancer	0.000996	0.00249	CcSEcCtD
Zonisamide—MAOB—head—head and neck cancer	0.000993	0.00253	CbGeAlD
Zonisamide—Urinary tract disorder—Docetaxel—head and neck cancer	0.000992	0.00248	CcSEcCtD
Zonisamide—Oedema peripheral—Docetaxel—head and neck cancer	0.00099	0.00247	CcSEcCtD
Zonisamide—Oedema—Fluorouracil—head and neck cancer	0.000989	0.00247	CcSEcCtD
Zonisamide—Connective tissue disorder—Docetaxel—head and neck cancer	0.000987	0.00247	CcSEcCtD
Zonisamide—Asthenia—Hydroxyurea—head and neck cancer	0.000986	0.00246	CcSEcCtD
Zonisamide—Urethral disorder—Docetaxel—head and neck cancer	0.000985	0.00246	CcSEcCtD
Zonisamide—CA2—lymphoid tissue—head and neck cancer	0.000984	0.00251	CbGeAlD
Zonisamide—Infection—Fluorouracil—head and neck cancer	0.000983	0.00245	CcSEcCtD
Zonisamide—CA5B—lymph node—head and neck cancer	0.00097	0.00247	CbGeAlD
Zonisamide—Nervous system disorder—Fluorouracil—head and neck cancer	0.00097	0.00242	CcSEcCtD
Zonisamide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000968	0.00242	CcSEcCtD
Zonisamide—Tachycardia—Fluorouracil—head and neck cancer	0.000965	0.00241	CcSEcCtD
Zonisamide—Vomiting—Vinblastine—head and neck cancer	0.000958	0.00239	CcSEcCtD
Zonisamide—CA4—head—head and neck cancer	0.000957	0.00244	CbGeAlD
Zonisamide—MAOA—thyroid gland—head and neck cancer	0.000955	0.00244	CbGeAlD
Zonisamide—Erythema multiforme—Docetaxel—head and neck cancer	0.00095	0.00237	CcSEcCtD
Zonisamide—Headache—Vinblastine—head and neck cancer	0.000944	0.00236	CcSEcCtD
Zonisamide—SCN3A—lymph node—head and neck cancer	0.000943	0.00241	CbGeAlD
Zonisamide—Anorexia—Fluorouracil—head and neck cancer	0.000943	0.00235	CcSEcCtD
Zonisamide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00094	0.00235	CcSEcCtD
Zonisamide—Eye disorder—Docetaxel—head and neck cancer	0.000939	0.00234	CcSEcCtD
Zonisamide—Hypotension—Fluorouracil—head and neck cancer	0.000924	0.00231	CcSEcCtD
Zonisamide—Dizziness—Hydroxyurea—head and neck cancer	0.000909	0.00227	CcSEcCtD
Zonisamide—Immune system disorder—Docetaxel—head and neck cancer	0.000908	0.00227	CcSEcCtD
Zonisamide—Mediastinal disorder—Docetaxel—head and neck cancer	0.000906	0.00226	CcSEcCtD
Zonisamide—AOX1—lymph node—head and neck cancer	0.000903	0.0023	CbGeAlD
Zonisamide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000901	0.00225	CcSEcCtD
Zonisamide—Nausea—Vinblastine—head and neck cancer	0.000895	0.00223	CcSEcCtD
Zonisamide—Insomnia—Fluorouracil—head and neck cancer	0.000895	0.00223	CcSEcCtD
Zonisamide—CA2—thyroid gland—head and neck cancer	0.000894	0.00228	CbGeAlD
Zonisamide—Paraesthesia—Fluorouracil—head and neck cancer	0.000888	0.00222	CcSEcCtD
Zonisamide—Alopecia—Docetaxel—head and neck cancer	0.000888	0.00222	CcSEcCtD
Zonisamide—Dyspnoea—Fluorouracil—head and neck cancer	0.000882	0.0022	CcSEcCtD
Zonisamide—Mental disorder—Docetaxel—head and neck cancer	0.00088	0.0022	CcSEcCtD
Zonisamide—Somnolence—Fluorouracil—head and neck cancer	0.000879	0.0022	CcSEcCtD
Zonisamide—Malnutrition—Docetaxel—head and neck cancer	0.000875	0.00218	CcSEcCtD
Zonisamide—Vomiting—Hydroxyurea—head and neck cancer	0.000874	0.00218	CcSEcCtD
Zonisamide—Dyspepsia—Fluorouracil—head and neck cancer	0.000871	0.00217	CcSEcCtD
Zonisamide—Rash—Hydroxyurea—head and neck cancer	0.000866	0.00216	CcSEcCtD
Zonisamide—Dermatitis—Hydroxyurea—head and neck cancer	0.000866	0.00216	CcSEcCtD
Zonisamide—Headache—Hydroxyurea—head and neck cancer	0.000861	0.00215	CcSEcCtD
Zonisamide—Decreased appetite—Fluorouracil—head and neck cancer	0.00086	0.00215	CcSEcCtD
Zonisamide—CA1—lymph node—head and neck cancer	0.000857	0.00219	CbGeAlD
Zonisamide—Dysgeusia—Docetaxel—head and neck cancer	0.000857	0.00214	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000854	0.00213	CcSEcCtD
Zonisamide—MAOA—head—head and neck cancer	0.000847	0.00216	CbGeAlD
Zonisamide—Muscle spasms—Docetaxel—head and neck cancer	0.000841	0.0021	CcSEcCtD
Zonisamide—Nausea—Hydroxyurea—head and neck cancer	0.000816	0.00204	CcSEcCtD
Zonisamide—Feeling abnormal—Fluorouracil—head and neck cancer	0.000815	0.00203	CcSEcCtD
Zonisamide—Anaemia—Docetaxel—head and neck cancer	0.000809	0.00202	CcSEcCtD
Zonisamide—CA2—head—head and neck cancer	0.000793	0.00202	CbGeAlD
Zonisamide—Urticaria—Fluorouracil—head and neck cancer	0.000786	0.00196	CcSEcCtD
Zonisamide—Syncope—Docetaxel—head and neck cancer	0.000784	0.00196	CcSEcCtD
Zonisamide—Leukopenia—Docetaxel—head and neck cancer	0.000783	0.00195	CcSEcCtD
Zonisamide—Body temperature increased—Fluorouracil—head and neck cancer	0.000782	0.00195	CcSEcCtD
Zonisamide—Palpitations—Docetaxel—head and neck cancer	0.000773	0.00193	CcSEcCtD
Zonisamide—Loss of consciousness—Docetaxel—head and neck cancer	0.000769	0.00192	CcSEcCtD
Zonisamide—Cough—Docetaxel—head and neck cancer	0.000763	0.00191	CcSEcCtD
Zonisamide—Convulsion—Docetaxel—head and neck cancer	0.000758	0.00189	CcSEcCtD
Zonisamide—Hypertension—Docetaxel—head and neck cancer	0.000755	0.00189	CcSEcCtD
Zonisamide—Myalgia—Docetaxel—head and neck cancer	0.000745	0.00186	CcSEcCtD
Zonisamide—Arthralgia—Docetaxel—head and neck cancer	0.000745	0.00186	CcSEcCtD
Zonisamide—Chest pain—Docetaxel—head and neck cancer	0.000745	0.00186	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00074	0.00185	CcSEcCtD
Zonisamide—Hypersensitivity—Fluorouracil—head and neck cancer	0.000729	0.00182	CcSEcCtD
Zonisamide—Dry mouth—Docetaxel—head and neck cancer	0.000728	0.00182	CcSEcCtD
Zonisamide—Confusional state—Docetaxel—head and neck cancer	0.00072	0.0018	CcSEcCtD
Zonisamide—Oedema—Docetaxel—head and neck cancer	0.000714	0.00178	CcSEcCtD
Zonisamide—Infection—Docetaxel—head and neck cancer	0.000709	0.00177	CcSEcCtD
Zonisamide—Shock—Docetaxel—head and neck cancer	0.000702	0.00175	CcSEcCtD
Zonisamide—Nervous system disorder—Docetaxel—head and neck cancer	0.0007	0.00175	CcSEcCtD
Zonisamide—Pruritus—Fluorouracil—head and neck cancer	0.0007	0.00175	CcSEcCtD
Zonisamide—Thrombocytopenia—Docetaxel—head and neck cancer	0.000699	0.00175	CcSEcCtD
Zonisamide—Tachycardia—Docetaxel—head and neck cancer	0.000697	0.00174	CcSEcCtD
Zonisamide—MAOB—lymph node—head and neck cancer	0.000695	0.00177	CbGeAlD
Zonisamide—Skin disorder—Docetaxel—head and neck cancer	0.000693	0.00173	CcSEcCtD
Zonisamide—Anorexia—Docetaxel—head and neck cancer	0.000681	0.0017	CcSEcCtD
Zonisamide—Diarrhoea—Fluorouracil—head and neck cancer	0.000677	0.00169	CcSEcCtD
Zonisamide—CA4—lymph node—head and neck cancer	0.00067	0.00171	CbGeAlD
Zonisamide—Hypotension—Docetaxel—head and neck cancer	0.000667	0.00167	CcSEcCtD
Zonisamide—Dizziness—Fluorouracil—head and neck cancer	0.000654	0.00163	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00065	0.00162	CcSEcCtD
Zonisamide—Insomnia—Docetaxel—head and neck cancer	0.000646	0.00161	CcSEcCtD
Zonisamide—Paraesthesia—Docetaxel—head and neck cancer	0.000641	0.0016	CcSEcCtD
Zonisamide—Dyspnoea—Docetaxel—head and neck cancer	0.000637	0.00159	CcSEcCtD
Zonisamide—Somnolence—Docetaxel—head and neck cancer	0.000635	0.00158	CcSEcCtD
Zonisamide—Vomiting—Fluorouracil—head and neck cancer	0.000629	0.00157	CcSEcCtD
Zonisamide—Dyspepsia—Docetaxel—head and neck cancer	0.000628	0.00157	CcSEcCtD
Zonisamide—Rash—Fluorouracil—head and neck cancer	0.000624	0.00156	CcSEcCtD
Zonisamide—Dermatitis—Fluorouracil—head and neck cancer	0.000623	0.00156	CcSEcCtD
Zonisamide—Decreased appetite—Docetaxel—head and neck cancer	0.000621	0.00155	CcSEcCtD
Zonisamide—Headache—Fluorouracil—head and neck cancer	0.00062	0.00155	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000616	0.00154	CcSEcCtD
Zonisamide—Fatigue—Docetaxel—head and neck cancer	0.000616	0.00154	CcSEcCtD
Zonisamide—Constipation—Docetaxel—head and neck cancer	0.000611	0.00152	CcSEcCtD
Zonisamide—MAOA—lymph node—head and neck cancer	0.000593	0.00151	CbGeAlD
Zonisamide—Feeling abnormal—Docetaxel—head and neck cancer	0.000588	0.00147	CcSEcCtD
Zonisamide—Nausea—Fluorouracil—head and neck cancer	0.000588	0.00147	CcSEcCtD
Zonisamide—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000584	0.00146	CcSEcCtD
Zonisamide—Body temperature increased—Docetaxel—head and neck cancer	0.000564	0.00141	CcSEcCtD
Zonisamide—Abdominal pain—Docetaxel—head and neck cancer	0.000564	0.00141	CcSEcCtD
Zonisamide—CA2—lymph node—head and neck cancer	0.000555	0.00142	CbGeAlD
Zonisamide—Hypersensitivity—Docetaxel—head and neck cancer	0.000526	0.00131	CcSEcCtD
Zonisamide—Asthenia—Docetaxel—head and neck cancer	0.000512	0.00128	CcSEcCtD
Zonisamide—Pruritus—Docetaxel—head and neck cancer	0.000505	0.00126	CcSEcCtD
Zonisamide—Diarrhoea—Docetaxel—head and neck cancer	0.000488	0.00122	CcSEcCtD
Zonisamide—Dizziness—Docetaxel—head and neck cancer	0.000472	0.00118	CcSEcCtD
Zonisamide—Vomiting—Docetaxel—head and neck cancer	0.000454	0.00113	CcSEcCtD
Zonisamide—Rash—Docetaxel—head and neck cancer	0.00045	0.00112	CcSEcCtD
Zonisamide—Dermatitis—Docetaxel—head and neck cancer	0.00045	0.00112	CcSEcCtD
Zonisamide—Headache—Docetaxel—head and neck cancer	0.000447	0.00112	CcSEcCtD
Zonisamide—Nausea—Docetaxel—head and neck cancer	0.000424	0.00106	CcSEcCtD
Zonisamide—CA6—Metabolism—GSTM1—head and neck cancer	0.000174	0.00084	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—MAPK1—head and neck cancer	0.000174	0.000837	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—EGFR—head and neck cancer	0.000174	0.000837	CbGpPWpGaD
Zonisamide—CA9—Metabolism—DPYD—head and neck cancer	0.000172	0.000831	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GPX1—head and neck cancer	0.000171	0.000826	CbGpPWpGaD
Zonisamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000171	0.000823	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CYP1A1—head and neck cancer	0.000169	0.000817	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—MAPK3—head and neck cancer	0.000169	0.000817	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MAPK3—head and neck cancer	0.000169	0.000815	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GPX1—head and neck cancer	0.000167	0.000805	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GPX1—head and neck cancer	0.000167	0.000805	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—MAPK1—head and neck cancer	0.000167	0.000804	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—MAPK1—head and neck cancer	0.000167	0.000804	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—EGFR—head and neck cancer	0.000167	0.000804	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—EGFR—head and neck cancer	0.000167	0.000804	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CYP1A1—head and neck cancer	0.000165	0.000797	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CYP1A1—head and neck cancer	0.000165	0.000797	CbGpPWpGaD
Zonisamide—CA7—Metabolism—TYMS—head and neck cancer	0.000165	0.000794	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—TYMS—head and neck cancer	0.000165	0.000794	CbGpPWpGaD
Zonisamide—CA9—Metabolism—YAP1—head and neck cancer	0.000164	0.000789	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GSTM1—head and neck cancer	0.000163	0.000784	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GSTM1—head and neck cancer	0.000163	0.000784	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—DPYD—head and neck cancer	0.000162	0.000784	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000161	0.000778	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—MAPK1—head and neck cancer	0.000161	0.000777	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MAPK1—head and neck cancer	0.000161	0.000776	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—EGFR—head and neck cancer	0.000161	0.000775	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000159	0.000767	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000157	0.000756	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTGS2—head and neck cancer	0.000156	0.000754	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GPX1—head and neck cancer	0.000156	0.000751	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GPX1—head and neck cancer	0.000156	0.000751	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—YAP1—head and neck cancer	0.000154	0.000744	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CYP1A1—head and neck cancer	0.000154	0.000744	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CYP1A1—head and neck cancer	0.000154	0.000744	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	0.000153	0.000739	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—HRAS—head and neck cancer	0.000153	0.000739	CbGpPWpGaD
Zonisamide—CA12—Metabolism—TYMS—head and neck cancer	0.000152	0.000735	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VEGFA—head and neck cancer	0.000151	0.00073	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GSTM1—head and neck cancer	0.000151	0.000727	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000151	0.000727	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—STAT3—head and neck cancer	0.00015	0.000722	CbGpPWpGaD
Zonisamide—CA13—Metabolism—AKT1—head and neck cancer	0.00015	0.000722	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000149	0.000717	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—HRAS—head and neck cancer	0.000148	0.000716	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—HRAS—head and neck cancer	0.000148	0.000715	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VEGFA—head and neck cancer	0.000146	0.000707	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—HRAS—head and neck cancer	0.000146	0.000703	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—STAT3—head and neck cancer	0.000145	0.0007	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GPX1—head and neck cancer	0.000144	0.000696	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VEGFA—head and neck cancer	0.000144	0.000694	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MAPK3—head and neck cancer	0.000143	0.00069	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CYP1A1—head and neck cancer	0.000143	0.000689	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—STAT3—head and neck cancer	0.000142	0.000687	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—HRAS—head and neck cancer	0.000141	0.000678	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—HRAS—head and neck cancer	0.000139	0.000672	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MAPK3—head and neck cancer	0.000139	0.000668	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—head and neck cancer	0.000138	0.000664	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTEN—head and neck cancer	0.000136	0.000658	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—STAT3—head and neck cancer	0.000136	0.000657	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MAPK1—head and neck cancer	0.000136	0.000657	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—EGFR—head and neck cancer	0.000136	0.000657	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MAPK3—head and neck cancer	0.000136	0.000656	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—head and neck cancer	0.000135	0.000652	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—HRAS—head and neck cancer	0.000134	0.000646	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—HRAS—head and neck cancer	0.000134	0.000646	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—UROD—head and neck cancer	0.000133	0.000639	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—head and neck cancer	0.000132	0.000638	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—head and neck cancer	0.000132	0.000638	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MAPK1—head and neck cancer	0.000132	0.000636	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EGFR—head and neck cancer	0.000132	0.000636	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—STAT3—head and neck cancer	0.000131	0.000631	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—STAT3—head and neck cancer	0.000131	0.000631	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—AKT1—head and neck cancer	0.000131	0.000631	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MAPK3—head and neck cancer	0.00013	0.000628	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MAPK1—head and neck cancer	0.000129	0.000625	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EGFR—head and neck cancer	0.000129	0.000625	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—HRAS—head and neck cancer	0.000129	0.000623	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—head and neck cancer	0.000127	0.000615	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—STAT3—head and neck cancer	0.000126	0.000609	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—head and neck cancer	0.000126	0.000606	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MAPK3—head and neck cancer	0.000125	0.000603	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MAPK3—head and neck cancer	0.000125	0.000603	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—AKT1—head and neck cancer	0.000124	0.000599	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MAPK1—head and neck cancer	0.000124	0.000597	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EGFR—head and neck cancer	0.000124	0.000597	CbGpPWpGaD
Zonisamide—CA4—Metabolism—TYMS—head and neck cancer	0.000122	0.000586	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MAPK3—head and neck cancer	0.000121	0.000582	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTM1—head and neck cancer	0.00012	0.00058	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MAPK1—head and neck cancer	0.000119	0.000574	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MAPK1—head and neck cancer	0.000119	0.000574	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—head and neck cancer	0.000119	0.000574	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—head and neck cancer	0.000119	0.000574	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000119	0.000574	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MAPK3—head and neck cancer	0.000119	0.000573	CbGpPWpGaD
Zonisamide—CA2—Metabolism—TYMS—head and neck cancer	0.000117	0.000562	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NAT2—head and neck cancer	0.000116	0.000561	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTM1—head and neck cancer	0.000115	0.000556	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GPX1—head and neck cancer	0.000115	0.000555	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MAPK1—head and neck cancer	0.000115	0.000553	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—head and neck cancer	0.000115	0.000553	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP1A1—head and neck cancer	0.000114	0.000549	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MAPK1—head and neck cancer	0.000113	0.000545	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—head and neck cancer	0.000113	0.000545	CbGpPWpGaD
Zonisamide—CA1—Metabolism—TYMS—head and neck cancer	0.000112	0.000539	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTM1—head and neck cancer	0.00011	0.000533	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GPX1—head and neck cancer	0.00011	0.000532	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—TYMS—head and neck cancer	0.00011	0.000528	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—HRAS—head and neck cancer	0.000109	0.000527	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP1A1—head and neck cancer	0.000109	0.000527	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTM1—head and neck cancer	0.000108	0.000522	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—HRAS—head and neck cancer	0.000106	0.000511	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GPX1—head and neck cancer	0.000106	0.00051	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP1A1—head and neck cancer	0.000105	0.000505	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—HRAS—head and neck cancer	0.000104	0.000501	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GPX1—head and neck cancer	0.000104	0.0005	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000103	0.000496	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP1A1—head and neck cancer	0.000103	0.000495	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—DPYD—head and neck cancer	0.000102	0.000492	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—head and neck cancer	0.000101	0.000486	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—HRAS—head and neck cancer	9.94e-05	0.00048	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TYMS—head and neck cancer	9.82e-05	0.000474	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—head and neck cancer	9.82e-05	0.000474	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—head and neck cancer	9.82e-05	0.000474	CbGpPWpGaD
Zonisamide—AOX1—Disease—NOTCH1—head and neck cancer	9.82e-05	0.000474	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTM1—head and neck cancer	9.71e-05	0.000468	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—YAP1—head and neck cancer	9.67e-05	0.000467	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—AKT1—head and neck cancer	9.65e-05	0.000466	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PIK3CA—head and neck cancer	9.62e-05	0.000464	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	9.56e-05	0.000461	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—HRAS—head and neck cancer	9.55e-05	0.000461	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—HRAS—head and neck cancer	9.55e-05	0.000461	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.55e-05	0.000461	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	9.43e-05	0.000455	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—AKT1—head and neck cancer	9.35e-05	0.000451	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GPX1—head and neck cancer	9.3e-05	0.000448	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TYMS—head and neck cancer	9.26e-05	0.000447	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—HRAS—head and neck cancer	9.21e-05	0.000444	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP1A1—head and neck cancer	9.2e-05	0.000444	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—AKT1—head and neck cancer	9.18e-05	0.000443	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—head and neck cancer	9.17e-05	0.000442	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—head and neck cancer	9.17e-05	0.000442	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTM1—head and neck cancer	9.15e-05	0.000441	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—MAPK1—head and neck cancer	9.11e-05	0.00044	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—HRAS—head and neck cancer	9.08e-05	0.000438	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	9.06e-05	0.000437	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—head and neck cancer	8.96e-05	0.000432	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	8.94e-05	0.000431	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—STAT3—head and neck cancer	8.87e-05	0.000428	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTEN—head and neck cancer	8.79e-05	0.000424	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—AKT1—head and neck cancer	8.78e-05	0.000424	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GPX1—head and neck cancer	8.76e-05	0.000423	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP1A1—head and neck cancer	8.67e-05	0.000418	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTEN—head and neck cancer	8.56e-05	0.000413	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTEN—head and neck cancer	8.56e-05	0.000413	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—head and neck cancer	8.49e-05	0.00041	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MAPK3—head and neck cancer	8.48e-05	0.000409	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—AKT1—head and neck cancer	8.44e-05	0.000407	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—AKT1—head and neck cancer	8.44e-05	0.000407	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—AKT1—head and neck cancer	8.13e-05	0.000392	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MAPK1—head and neck cancer	8.07e-05	0.000389	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—head and neck cancer	8.07e-05	0.000389	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTEN—head and neck cancer	8e-05	0.000386	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTEN—head and neck cancer	8e-05	0.000386	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—UROD—head and neck cancer	7.97e-05	0.000384	CbGpPWpGaD
Zonisamide—CA3—Metabolism—AKT1—head and neck cancer	7.86e-05	0.000379	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTEN—head and neck cancer	7.41e-05	0.000357	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—HRAS—head and neck cancer	7.32e-05	0.000353	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—head and neck cancer	7.29e-05	0.000352	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—head and neck cancer	6.77e-05	0.000327	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—head and neck cancer	6.49e-05	0.000313	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—head and neck cancer	6.48e-05	0.000312	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—head and neck cancer	6.36e-05	0.000307	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—head and neck cancer	6.23e-05	0.0003	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—head and neck cancer	6.2e-05	0.000299	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—head and neck cancer	6.11e-05	0.000295	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—head and neck cancer	6.04e-05	0.000291	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—head and neck cancer	6.04e-05	0.000291	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—head and neck cancer	5.91e-05	0.000285	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.84e-05	0.000282	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TYMS—head and neck cancer	5.81e-05	0.00028	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.79e-05	0.000279	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTM1—head and neck cancer	5.74e-05	0.000277	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—head and neck cancer	5.72e-05	0.000276	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—head and neck cancer	5.69e-05	0.000274	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—head and neck cancer	5.66e-05	0.000273	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—head and neck cancer	5.64e-05	0.000272	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—head and neck cancer	5.64e-05	0.000272	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NAT2—head and neck cancer	5.5e-05	0.000265	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GPX1—head and neck cancer	5.5e-05	0.000265	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—head and neck cancer	5.47e-05	0.000264	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1A1—head and neck cancer	5.44e-05	0.000263	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK3—head and neck cancer	5.43e-05	0.000262	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—head and neck cancer	5.43e-05	0.000262	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—head and neck cancer	5.32e-05	0.000257	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—head and neck cancer	5.23e-05	0.000252	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK1—head and neck cancer	5.17e-05	0.000249	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—head and neck cancer	5.17e-05	0.000249	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—head and neck cancer	5.16e-05	0.000249	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—head and neck cancer	5.06e-05	0.000244	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—head and neck cancer	4.94e-05	0.000238	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—head and neck cancer	4.94e-05	0.000238	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—DPYD—head and neck cancer	4.83e-05	0.000233	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—head and neck cancer	4.77e-05	0.00023	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—head and neck cancer	4.61e-05	0.000222	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—head and neck cancer	4.61e-05	0.000222	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—YAP1—head and neck cancer	4.58e-05	0.000221	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—head and neck cancer	4.5e-05	0.000217	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—head and neck cancer	4.49e-05	0.000216	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—head and neck cancer	4.27e-05	0.000206	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—head and neck cancer	4.17e-05	0.000201	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—head and neck cancer	4.15e-05	0.0002	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—head and neck cancer	4e-05	0.000193	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—head and neck cancer	3.83e-05	0.000185	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—head and neck cancer	3.76e-05	0.000181	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—head and neck cancer	3.66e-05	0.000177	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.44e-05	0.000166	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—head and neck cancer	3.4e-05	0.000164	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—head and neck cancer	3.37e-05	0.000162	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAT2—head and neck cancer	3.31e-05	0.00016	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—head and neck cancer	3.26e-05	0.000157	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—head and neck cancer	3.24e-05	0.000156	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—head and neck cancer	3.17e-05	0.000153	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—head and neck cancer	3.13e-05	0.000151	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—head and neck cancer	3.07e-05	0.000148	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3e-05	0.000145	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—DPYD—head and neck cancer	2.9e-05	0.00014	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—head and neck cancer	2.82e-05	0.000136	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—YAP1—head and neck cancer	2.75e-05	0.000133	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—head and neck cancer	2.75e-05	0.000133	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TYMS—head and neck cancer	2.75e-05	0.000133	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.72e-05	0.000131	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPX1—head and neck cancer	2.6e-05	0.000126	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—head and neck cancer	2.59e-05	0.000125	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.58e-05	0.000124	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.12e-05	0.000102	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—head and neck cancer	1.99e-05	9.61e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TYMS—head and neck cancer	1.65e-05	7.98e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.63e-05	7.88e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—head and neck cancer	1.63e-05	7.85e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPX1—head and neck cancer	1.57e-05	7.55e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.55e-05	7.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.53e-05	7.39e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—head and neck cancer	1.34e-05	6.45e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—head and neck cancer	9.43e-06	4.55e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—head and neck cancer	9.21e-06	4.44e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—head and neck cancer	8.04e-06	3.88e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—head and neck cancer	7.7e-06	3.71e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.67e-06	2.73e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—head and neck cancer	4.63e-06	2.23e-05	CbGpPWpGaD
